Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688076'
s FCF Margin % Range Over the Past 10 Years
Min: -389.89 Med: -37.5 Max: 5.31
Current: -25.77
During the past 13 years, the highest FCF Margin % of Sinopep Allsino Bio Pharmaceutical Co was 5.31%. The lowest was -389.89%. And the median was -37.50%.
SHSE:688076's FCF Margin % is ranked better than 61.26% of 950
companies
in the Biotechnology industry
Industry Median: -81.28
vs SHSE:688076: -25.77
Sinopep Allsino Bio Pharmaceutical Co FCF Margin % Related Terms
Sinopep Allsino Bio Pharmaceutical Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopep Allsino Bio Pharmaceutical Co FCF Margin % Chart
SHSE:688076 vs VRTX, REGN, ALNY: FCF Margin % Comparison
For the Biotechnology subindustry, Sinopep Allsino Bio Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopep Allsino Bio Pharmaceutical Co FCF Margin % vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) has a FCF Margin % of -3.51% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sinopep Allsino Bio Pharmaceutical Co and its competitors. According to the industry distribution chart, Sinopep Allsino Bio Pharmaceutical Co ranks #368 out of 950 companies in the Biotechnology industry, placing it in the top 38.7%.
Is Sinopep Allsino Bio Pharmaceutical Co's FCF Margin % too high?
Sinopep Allsino Bio Pharmaceutical Co's current FCF Margin % is -3.51%. Based on the distribution chart, Sinopep Allsino Bio Pharmaceutical Co ranks #368 out of 950 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sinopep Allsino Bio Pharmaceutical Co has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopep Allsino Bio Pharmaceutical Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sinopep Allsino Bio Pharmaceutical Co ranks #368 out of 950 companies for FCF Margin %. This puts Sinopep Allsino Bio Pharmaceutical Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sinopep Allsino Bio Pharmaceutical Co and its competitors. Sinopep Allsino Bio Pharmaceutical Co's current FCF Margin % is -3.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopep Allsino Bio Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥58.87, compared to a current price of ¥28.00 — trading 52.4% below its estimated fair value. The current FCF Margin % is -3.51%. Sinopep Allsino Bio Pharmaceutical Co's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076), the current FCF Margin % is -3.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopep Allsino Bio Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥28.00 is trading 52.4% below its estimated GF Value™ of ¥58.87.
GuruFocus considers Sinopep Allsino Bio Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for SHSE:688076:
FCF Margin %: -3.51%
GF Value™: ¥58.87 vs. price of ¥28.00 (52.4% below fair value)
No single metric tells the full story. See the SHSE:688076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sinopep Allsino Bio Pharmaceutical Co Business Description
Sinopep Allsino Bio Pharmaceutical Co Ltd is a market-oriented, research and development and innovation-driven biomedical enterprise focusing on the research, development, production and sales of peptide drugs and small molecule chemical drugs.
65GF Score
Get the complete analysis for SHSE:688076
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688076 has been successfully added to your 
